AGP Executive Report
Last update: 17 minutes agoMedical Cannabis Outcomes: Minnesota officials report that among 1,800 autism patients in the state program, many saw clinically meaningful drops in anxiety, depression, and sleep issues after starting medical cannabis. Neuroscience & Safety: A Northwestern study links cannabinoid-triggered anxiety to specific brain neurons, helping explain why some users feel calm then suddenly panic. Patient Feedback Push: Virginia’s Cannabis Control Authority is rolling out a satisfaction survey to learn how patients use medical marijuana and where they get products, aiming to improve the program. Regulatory Watch: Michigan lawmakers are escalating scrutiny of kratom over rising poisonings, while federal cannabis rescheduling faces a pause after process concerns. Industry & Supply Chain: Ireland’s Dunbar Pharma, making plant-derived cannabinoid APIs, is named a finalist for a major start-up founder award. Local Cannabis Policy: Charles County, Maryland approved a temporary moratorium on most cannabis growing zones while it reviews where larger operations should go. Hemp Under Pressure: West Virginia’s Moon Flower warns federal THC restrictions could threaten its hemp business.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
